Chief Executive Officer & President
Mr. Augusti has served as our President and Chief Executive Officer and as a member of our board of directors since November 2016. Prior to joining us, Mr. Augusti was Integra LifeSciences Corporation’s Corporate Vice President, and President of Orthopedics and Tissue Technologies. Mr. Augusti was responsible for the management of the Orthopedics and Tissue Technologies global division, which includes extremity implants, tissue products, and the Private Label business.
His responsibilities included U.S. commercial leadership, global portfolio management, evaluation of corporate development opportunities and overall strategic direction. He joined Integra in April 2014 as Corporate Vice President and President of Orthopedics and Tissue Technologies, and brings over 25 years of executive management experience in medical technology. Prior to joining Integra, Mr. Augusti served as Chief Executive Officer at Bioventus LLC, from May 2012 to August 2013, and was a member of the company’s Board of Directors during the same period. Prior to that Mr. Augusti spent nine years with Smith & Nephew, from April 2003 to April 2012, in a series of leadership roles, including President of Smith & Nephew’s Biologic Division, where he was appointed to lead Smith & Nephew’s new biologics initiative. He also served as Smith & Nephew’s President of the Orthopaedic Trauma & Clinical Therapies Global Business and Senior Vice President and General Manager of the Trauma business. Prior to that, from 1987 to 2000, he spent 13 years at GE Medical Systems, where he held various sales, marketing and strategic management roles, both in the U.S. and internationally. Mr. Augusti received his M.B.A. from the UCLA Anderson School of Management, and his B.S. in Computer Science and Economics from Duke University.Read More
Chief Financial Officer and Treasurer
Mr. Howe has served as our Chief Financial Officer (CFO) and Treasurer since February 2020. He is a senior finance professional with more than 20 years of progressive experience at public medical device companies in roles that encompass financial planning and analysis (FP&A), financial reporting, and business strategy. Most recently, he spent nearly five years at NxStage Medical, Inc., as VP of Finance and Corporate Controller, responsible for corporate FP&A, external financial reporting, manufacturing finance, shared service functions, Tax, and Treasury. He also led all aspects of financial controls and external audit activities and drove operational improvements through shared service implementation and systems automation.
Immediately prior to this, Mr. Howe served at Lake Region Medical as VP, FP&A – Cardio & Vascular Division, where he progressed from Senior Director of FP&A for its Advanced Surgical Division. Before this, he served for 17 years at Boston Scientific where he held financial leadership roles in three of the company’s operating divisions as well as senior roles in manufacturing and corporate finance.
Mr. Howe earned an MBA degree at Boston University and a BS degree in Finance and Entrepreneurial Studies at Babson College.
Christine Desrochers, Controller
Allison Baker, Human Resources
J. Brent Alldredge
Chief Legal Officer
Mr. Alldredge has served as our Chief Legal Officer and Corporate Secretary since July 2019. Prior to joining us, Mr. Alldredge was the Senior Vice President, Deputy General Counsel, and Assistant Corporate Secretary of Orthofix Medical Inc., a diversified global medical device company, from August 2016 until July 2019. Before that, Mr. Alldredge served in various roles of increasing responsibility with Orthofix, including Interim General Counsel and Corporate Secretary, and Vice President, Deputy General Counsel, and Assistant Corporate Secretary. Before joining Orthofix in January 2011, Mr. Alldredge was an attorney at Baker & McKenzie LLP, a leading global law firm, and also served as briefing attorney and law clerk to the Chief Justice of Texas’ Sixth District Court of Appeals. Mr. Alldredge is a graduate of Brigham Young University and earned his Juris Doctorate from Southern Methodist University Dedman School of Law, where he served as the Managing Editor of the SMU Law Review.
Senior Vice President, Quality and Regulatory Affairs
Mr. Emmanuel O. Nyakako has served as our Senior Vice President of Quality and Regulatory since March, 2017. Prior to joining us, Mr. Nyakako managed his QA/RA consulting company between July 2016 and March 2017. Prior to that, Mr. Nyakako was Corporate Vice President of Quality and Regulatory Affairs at Hologic Inc., between April 2015 and July 2017 managing Global and Corporate functions of Quality and Regulatory Affairs. He was the Senior Vice President of Quality, Regulatory and Clinical Affairs at Zimmer-Biomet from Sept. 2012-April 2015 at the time when Zimmer acquired Biomet, he led the combined organization.
Mr. Nyakako spend over 6 years at Flextronics Corporation as Vice President of Quality and Regulatory Affairs, 7 years in Nypro, Inc. (currently Jabil) as Director of QA/RA. Mr. Nyakako spend time at J&J, Coltene-Weldant, Biomet Inc., in his over 36 years in manufacturing, quality and regulatory affairs career progression. Mr. Nyakako has a MS Geological Sciences (Montclair State University NJ), BS in Business Administration (Ramapo College, NJ) and Diploma in Mechanical Engineering (Polytechnic, Nairobi, Kenya).Read More
Senior Vice President, Product Engineering
Mr. Slamin has served as our Senior Vice President, Product Engineering since October 2007, with responsibility for overseeing all product engineering and development of our knee implants. Before joining us, Mr. Slamin spent more than 30 years in research and development at Johnson & Johnson’s Orthopaedic Division, now DePuy, where he was responsible for product development activities. Mr. Slamin is the holder of seven patents related to knee implant engineering. Mr. Slamin has an Associate Degree in Mechanical Engineering from Wentworth Institute of Technology in Boston, Massachusetts
Senior Vice President, Operations
Mr. Maingot has served as our SVP, Operations since January 2020. He has more than 25 years of progressive experience within the medical device industry and a track record of solving complex problems in the interdependent functions of quality, engineering, operations, and supply chain.
Immediately prior to joining Conformis, Mr. Maingot served at Spinal Elements, Inc. for three years as EVP, Operations, responsible for manufacturing, supply chain, distribution, and customer service. By eliminating bottlenecks there, he achieved a significant increase in production output within six months. He also implemented a sales and operations planning process that drove backorders down and improved line fill rates.
Prior to Spinal Elements, Mr. Maingot served at Oscor, Inc. as VP of Global Operations & Supply Chain, responsible for all operations and supply chain functions. Before this, he served at Biomet, progressing to Group Vice President Operations & Supply Chain at Biomet Spine, Bone Healing, and Microfixation. With Biomet, he led the supply chain teams for three multi-site business units with more than $400 million in revenue, and developed a supply chain strategy, structure, and culture to partner with commercial functions. Mr. Maingot was also involved in ensuring the success of significant business integrations. Beginning his career at Johnson & Johnson as Quality Engineer, he also served as Manufacturing Engineering Manager, Operations Manager, and Engineer at Boston Scientific and Medtronic.
Mr. Maingot earned an MBA degree at Babson College, an MS degree in Industrial Engineering at the University of South Florida, and a BS degree in Statistics at the University of Western Ontario. He is also a Certified Six Sigma Black Belt.
Vice President, Clinical Affairs & Market Access
Mr. Quartulli has served as our Vice President, Clinical Affairs & Market Access since June 2019. From April 2015 to May 2019 he was our Vice President, Clinical Affairs. From July 2011 to March 2015, he was our Senior Director, Clinical Affairs. Prior to joining us, Mr. Quartulli served as a consultant for Globus Medical from January 2011 to Jun 2011 following their acquisition of Facet Solutions, Inc., a manufacturer of spinal implants, where he had served as director of clinical affairs from March 2006 to December 2010. Prior to that, he served as a clinical manager at NDO Surgical, Inc. and as a senior clinical research associate at Boston Scientific. Mr. Quartulli has over 18 years of experience in clinical research which began at Dana-Farber Cancer Institute, where he advanced through positions of increasing responsibility in clinical affairs roles. Mr. Quartulli has a B.S. in Biology from Siena College.
Vice President of U.S. Marketing
Mr. Khaghani has served as our Vice President of U.S. Marketing since rejoining Conformis in June 2020. In this position, his functional areas of responsibility include product management for the knee and hip product lines, medical education, events, and marketing communication. While away from Conformis, he served as President of NextStep Arthropedix, and as SVP Sales & Marketing at RF Technologies before that. During his original term with Conformis of more than 10 years, Mr. Khaghani progressed from Senior Director, Product Management to Area Vice President, Sales for the East Region of the U.S.
Before his initial employment at Conformis, Mr. Khaghani served as Product Director at DePuy Spine and Johnson & Johnson for 5 years, where he managed a key line and new product launches, developed marketing strategies, and worked with various promotional agencies on product branding and literature. Prior to that, he served as Director of Operations of Win Enterprises for 3 years. Before that, he served in engineering and operations management positions in the medical and high-tech fields.
Mr. Khaghani earned BS degrees in Biology and Mathematics at Cornell University; an MS degree in Mechanical Engineering at Boston University; and an Executive MBA degree at Suffolk University’s Sawyer School of Management, with a concentration in Finance. He is also a member of the External Advisory Board for the Graduate School of Biomedical Science and Engineering at the University of Maine.